Anterior Quadratus Lumborum Block as a Component of Multimodal Analgesia for Abdominal Hysterectomies
CompletedNot applicableNCT07046949
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The main goal of this randomised double-blinded controlled trial is to assess whether adding anterior quadratus lumborum block preoperatively can reduce intraoperative and postoperative opioid consumption, reduce pain after abdominal hysterectomy and improve quality of recovery after anesthesia. The study hypothesis is that anterior QL block bilaterally before the start of a surgery has no impact on perioperative pain relief, can't reduce the need in opioids and will not improve quality of recovery after anesthesia. All patients will undergo general anesthesia with tracheal intubation and mechanical ventilation. Patients will be randomized into two groups. In addition to general anesthesia and multimodal analgesia with parenteral medication II (QL) group will receive also anterior quadratus lumborum block as a regional component.
Study details
- Official title
- A Randomized Controlled Double-blinded Trial Evaluating the Efficacy of the Anterior Quadratus Lumborum Block as a Component of Multimodal Perioperative Analgesia for Abdominal Hysterectomies
- Conditions
- Uterine Bleeding
- Uterine Neoplasms
- Uterine Diseases
- Uterine Fibroids
- Interventions
- Procedure: ANTERİOR QUADRATUS LUMBORUM BLOCK
- Drug: Parenteral administration of analgesics
- Procedure: General Anesthesia (GA)
- Sponsor
- Yuri Semenyuk Rivne Regional Clinical Hospital
- Collaborators
- Danylo Halytsky Lviv National Medical University
- Start date
- 2025-07-07
- Primary completion
- 2025-12-08
- Sex
- Female
- Age range
- from 40 Years to 55 Years
- Results posted
- No results posted in this snapshot
- Countries
- Ukraine
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * patients with ASA status I-II * patients with symptomatic fibroids * patients scheduled for abdominl hysterectomy Exclusion Criteria: * refusal to participate in the study at any of its stages * ASA class ≥ III * body mass index \> 40 kg/m2 * use of opiate receptor agonists/antagonists before surgery * uncontrolled hypertension
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07046949